Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation

Aylin Akifova; Klemens Budde; Mira Choi; Michael Oellerich; Julia Beck; Kirsten Bornemann-Kolatzki; Ekkehard Schütz; Jan Kowald; Bilgin Osmanodja

doi:10.1016/j.ekir.2023.07.011

Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation

Kidney Int Rep. 2023 Jul 21;8(10):2141-2145. doi: 10.1016/j.ekir.2023.07.011. eCollection 2023 Oct.

Authors

Aylin Akifova¹, Klemens Budde¹, Mira Choi¹, Michael Oellerich², Julia Beck³, Kirsten Bornemann-Kolatzki³, Ekkehard Schütz³, Jan Kowald⁴, Bilgin Osmanodja¹

Affiliations

¹ Department of Nephrology and Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
² Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
³ Chronix Biomedical GmbH, Göttingen, Germany.
⁴ Medical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany.

No abstract available

Keywords: antibody-mediated rejection; biomarker; donor-derived cell-free DNA; kidney transplantation; molecular diagnostic techniques; recurrent IgA nephropathy.